Catalent Pharma Solutions 3Q Revenues: $453.3 million (+4%) 3Q Loss: $31 million (earnings were $21.8 million in 1Q07) YTD Revenues: $1.4 billion (+8%) YTD Loss: $72.5 million (earnings were $41.4 million YTD07) Comments: The company attributed its revenue growth primarily to the effect of a weaker dollar. Without that factor, net revenues would have declined 2%, due primarily to lower North American volumes in printed components and commercial packaging. Sterile Technologies reve...